Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE)

74 filings reported holding CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share as of Q1 2020.
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 12,051,516 shares of 43,411,663 outstanding shares and own 28% of the company stock.
Largest 10 shareholders include Nantahala Capital Management, LLC (2,503,840 shares), Avoro Capital Advisors LLC (1,870,000 shares), BlackRock Inc. (1,329,428 shares), Slate Path Capital LP (870,694 shares), Corriente Advisors, LLC (820,000 shares), MANGROVE PARTNERS (601,398 shares), Prosight Management, LP (552,060 shares), STATE STREET CORP (371,783 shares), 683 Capital Management, LLC (320,000 shares), and GEODE CAPITAL MANAGEMENT, LLC (308,587 shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.